Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Automated AI Reads Electronic Health Records

By HospiMedica International staff writers
Posted on 22 Sep 2021
A new study shows how an artificial intelligence (AI)-based algorithm can read electronic health record (EHR) data to identify certain diseases.

The Phe2vec algorithm, developed by researchers at the Icahn School of Medicine at Mount Sinai (MSSM; New York, NY, USA) and the University of Potsdam (Germany), uses unsupervised machine learning (ML) to derive conceptual relationships between EHR data and a host of known diseases. More...
The algorithm relies on embedding previous algorithms, developed by other researchers (such as linguists), to study word networks in various languages.

To test its performance, Phe2vec attempted to identify the diagnoses of nearly two million patients whose data was stored in the MSSM EHR. Results showed that for nine out of ten diseases tested, the system was as effective as, or even slightly better than, the gold standard manual phenotyping process, correctly identifying diagnoses of dementia, multiple sclerosis, and sickle cell anemia, among others. The study was published on September 2, 2021, in Patterns.

“There continues to be an explosion in the amount and types of data electronically stored in a patient’s medical record. Disentangling this complex web of data can be highly burdensome,” said senior author Benjamin Glicksberg, PhD, of the MSSM Hasso Plattner Institute for Digital Health (HPIMS). “Phe2vec aims to contribute to the next generation of clinical systems that use machine learning to offer a more holistic way to examine disease complexity and to improve clinical practice and medical research.”

Currently, scientists rely on a system called the Phenotype Knowledgebase (PheKB) to mine medical records for new information. To study a disease, researchers first have to comb through reams of medical records looking for pieces of data, such as certain lab tests or prescriptions, which are uniquely associated with the disease. They then program an algorithm to search for patients who have those disease-specific pieces of data (the phenotype). Each time researchers want to study a new disease, they have to restart this process from scratch.

Related Links:

Icahn School of Medicine at Mount Sinai
University of Potsdam


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.